Medtronic plc (MDT) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for Medtronic plc (MDT): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 54/100 — a percentile rank of Medtronic plc’s fundamentals against Manufacturing peers, weakest on financial health. A quality ranking, not a price prediction.
| Market cap | $110.4B |
| P / E | 21.1× |
| P / S | 2.9× |
| EV / EBITDA | 13.6× |
| Gross margin | 65.0% |
| Operating margin | 17.9% |
| Net margin | 14.0% |
| Return on equity | 10.4% |
| ROIC | 6.9% |
| Revenue growth | 9.8% |
| Debt / equity | 0.6× |
| Dividend yield | 3.3% |
Is Medtronic plc overvalued? P/E looks undervalued vs its 5-year range; P/S looks undervalued vs its 5-year range; EV/EBITDA looks undervalued vs its 5-year range; P/B looks fair vs its 5-year range.
Independent of the events above — derived from Medtronic plc’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact